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Summary
Spray chilling technology (also known as spray cooling and spray congealing technol-
ogy) has been widely studied and used in the pharmaceutical field. In the food industry,
this technique is gaining interest and can become useful because functional food formula-
tions can be developed. Spray chilling is a fat-based system, which involves the addition
of the component of interest to a molten lipid carrier, and the resulting mixture is fed
through an atomiser nozzle. When the nebulised material is put into contact with the envi-
ronment, which is cooled below the melting point of the matrix material, the vehicle solid-
ifies (due to heat exchange between the molten material and cold air), and solid lipid
microparticles are formed at the same time. This technology is fat based, and lipid carriers,
such as wax and oil (e.g. palm oil, beeswax, cocoa butter, and kernel oil) can be used. This
encapsulation technique can potentially change the functionality, reduce the hygroscopicity,
mask taste or odour, change solubility, and provide physical protection in addition to al-
lowing the controlled release of these ingredients. This low-cost technology is relatively
simple to apply and scale up, and it does not require the use of organic solvents and the
application of high temperatures in the process. Therefore, spray chilling encapsulation
may facilitate the development and production of functional and enriched foods as it may
solve some technological problems associated with the use of certain ingredients, such as
those that have high reactivity and low stability.
Key words: spray cooling, spray congealing, nutrient microencapsulation, solid lipid micro-
particles (SLMs), bioactive compounds
Introduction
The use of encapsulation technology has increased
in the last 10 years to address some limitations in the
use of medicines, food ingredients, cosmetics, veterinary
products and hygiene products. The most popular tech-
niques used to develop microparticles are spray coating,
coacervation, solvent evaporation, ionic gelation, lipo-
somes, spray drying and spray chilling (also known as
spray cooling and spray congealing).
Spray chilling technology consists of making a solu-
tion dispersion or emulsion containing the active ingre-
dient and a molten carrier, which is then atomised into a
chamber where cold air or liquid nitrogen is injected. In
the case of emulsions, spray chilling technology can be
applied to a water-in-fat emulsion in the presence of an
emulsifier, such as soy lecithin (1–4). Under these condi-
tions, the carrier instantly solidifies, forming spherical
particles, and the solubility of these particles depends on
the hydrophilic/lipophilic nature of the carriers. These
particles can be as small as a microparticle depending
mainly on the device used for the atomisation process.
To meet food industry requirements, carriers must be
food grade. Lipophilic materials that have a melting
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point higher than room temperature are mostly used,
thus yielding solid lipid microparticles (SLMs). The most
recommended carriers for the development of particles
by means of spray chilling are fatty acids, alcohols, tri-
acylglycerols and waxes.
Spray chilling is a convenient technique for the en-
capsulation of food ingredients because it is a low-cost
continuous process, and it is easy to scale up. Moreover,
spray chilling does not require organic solvents, such as
alcohols or ether, and it does not require application of
high temperatures, which should be considered when
thermosensitive ingredients, such as w-3 fatty acids, en-
zymes and probiotics, need to be encapsulated. However,
spray chilling encapsulation presents some technological
disadvantages, such as low encapsulation efficiency and
the possibility of expulsion of the active ingredient dur-
ing storage. Another disadvantage of spray chilling en-
capsulation is related to the hydrophobic character of
the particles, which can make some applications diffi-
cult.
There is no consensus in the literature regarding the
nomenclature of the spray chilling encapsulation tech-
nique, which can be considered synonymous with spray
cooling (5,6) and spray congealing (7–10). There is often
overlapping of terms in technical and scientific litera-
ture. The terms spray chilling and spray cooling are nor-
mally used when taking into consideration the melting
point of the carrier. Herein, spray chilling is the process
that uses carriers with a melting point between 32 and
42 °C for the production of spray particles, and spray
cooling is the encapsulation process in which the carrier
has a melting point between 45 and 122 °C (11–14).
The term spray congealing is employed indiscriminately
when molten carriers are used regardless of their melt-
ing temperature (15,16). However, this impasse or the
lack of consensus regarding the right terminology does
not obscure the real importance of this encapsulation
technology.
Currently, many publications are available in the lit-
erature describing the preparation of lipid particles by
spray chilling for different purposes as follows: flavour
and odour masking, production of ingredients with in-
creased stability, protection and controlled release of pro-
biotics, and encapsulation of bioactive proteins and pep-
tides. However, most studies are from the pharmaceutical
field, and there has not been an article published regard-
ing the compilation of such data for the food industry.
Based on these considerations, the purpose of the pres-
ent article is to highlight the importance of spray chill-
ing encapsulation in food fields.
Spray Chilling Technology
In general, the spray chilling process can be divided
into two steps. The first step consists of adding the bio-
active compound to the carrier material, which is usu-
ally a lipophilic compound, to be encapsulated. This in-
corporation process can be performed by dissolving or
mechanically dispersing the material into the encapsu-
lating matrix (the latter is the most widely applied meth-
od). The use of an emulsion is also a method to incorpo-
rate some hydrophilic bioactive agents (2–4). The second
step consists of atomisation of the molten material, which
is typically carried out by a heated atomising nozzle to
maintain a proper temperature, thus avoiding solidifica-
tion of the feeding material. When this material is atom-
ised in contact with a refrigerated chamber (due to the
injection of cold air or liquid N2), a heat transfer occurs
between the molten material and the cold air, thus lead-
ing to solidification of the carrier and the formation of
particles (5).
The residence time of droplets in the spray cooling
chamber is relatively short (only a few seconds). The par-
ticles are collected in a container located below the cool-
ing chamber, and fine particles are transported by air
into a cyclone where they are collected in another con-
tainer (Fig. 1).
The preparation of particles using this method has
been applied in various sectors, including pharmaceuti-
cal, cosmetic, agricultural, veterinary and food industry
(1). The application of spray chilling encapsulation pro-
cess has also been reported for the production of both
food ingredients and several drugs (17).
Numerous applications of SLMs obtained by spray
chilling have been investigated, such as odour and taste
masking (18,19); protection of the active ingredient against
detrimental conditions, such as pH, enzyme activity,
moisture, oxygen and light; optimisation of the dissolu-
tion of poorly soluble drugs; modulating the release ki-
netics of active compounds; and improvement of flow
properties, handling, appearance and other purposes (8).
If lipids are used as the carrier material, the final
product is insoluble in water and there is usually con-
trolled release of its contents by utilising the melting
point of the carrier (20) or by digestion of the carrier in
the intestine. The proper selection of the carrier is crucial
because the encapsulation process can modify its prop-
erties, such as reduce its hygroscopicity and/or increase
its chemical/physical stability (18).
The atomisation of the molten mixture (carrier plus
active ingredient) and the solidification process are con-
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Fig. 1. Scheme of spray chilling equipment
sidered critical steps. The atomisation process is related
to the disintegration of the molten mixture into small
particles (21), and the solidification process is associated
with the processing of the molten material into a solid
(obtained by cooling). From the operational standpoint,
insufficient cooling leads to agglomeration of the drop-
lets and/or adhesion of these droplets on the surface of
the chamber, thus negatively affecting the morphology,
process and other properties of the microparticles.
Spray chilling is similar to spray drying, which is a
widely studied and widespread technology. However,
there is a difference between these processes in terms of
direction of energy flow. With regard to spray drying,
the energy is applied to the droplet forcing the solvent
evaporation. In spray chilling encapsulation, however, the
energy is removed from the droplet forcing the solidifi-
cation of the carrier (5). The spray chilling technique may
be considered to be a merger between the hot melt tech-
nology (coating or agglomeration) and the spray drying
technique. Table 1 (5,8,10,14,22–25) presents several dif-
ferences between these techniques (spray chilling and
spray drying).
The initial spray chilling configuration is similar to
the spray drying configuration, but there is no solvent
evaporation. A conventional spray dryer (when there is
input of hot air) can also be used as a spray cooler (when
there is input of cold air). The apparatus consists of two
main parts: a cooling chamber and an atomiser. For an
efficient process, it is recommended that the molten mix-
ture dispersion presents a narrow melting temperature
range, so the particles can also be solidified during the
spraying process (26).
Both spray drying and spray chilling techniques do
not produce reservoir-type microcapsules, but instead
they produce matrix-type microspheres. However, spray
chilling produces dense and massive microspheres, and
spray drying generally produces hollow microspheres
(Fig. 2).
There are also similarities between the SLMs ob-
tained by the spray chilling technology and by the spray
coating technology. These methods can both be fat based,
and the physical nature of these processes is similar be-
cause they have the same release mechanisms that differ
from the spray drying regarding the functionality of par-
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Table 1. Differences between spray chilling and spray drying techniques
Spray drying Spray chilling Ref.
Energy flow energy applied in the droplet forcing
evaporation of the medium
energy removed from the droplet forcing
the solidification of the medium
(5)
Equipment feeding tubes without heating heated feeding tubes (to avoid solidification) (8)
Flow in the chamber hot air cold air or liquid N2 (8)
Particle size 5–150 mm 20–200 mm (14)
Dissolution mechanism dissolution diffusion, heating, lipases and bile salts (GI
tract)
(22)
Particle morphology geometric particle with porous and irregular
surface due to solvent evaporation
dense, spherical and smooth surface
(no effects of solvent evaporation)
(23)
Carrier water-soluble polymers waxes, fatty acids, water-soluble polymers
and water-insoluble monomers
(24)
Food ingredients vitamins, flavours, starter cultures, carotenoids,
oils, fats, enzymes and acidulants
iron sulphate, vitamins, minerals, acidulants,
enzymes and probiotics
(25)
Process steps dispersing or dissolving the active compound
in aqueous solution coating, atomisation,
dehydration
dispersing or dissolving the active
compound in the molten lipid mixture,
atomisation, cooling
(10)
Load/% 5–50 10–20 (10)
Fig. 2. Differences between particles produced by spray drying and spray chilling: a) micrograph of a fractured particle produced by
spray chilling, b) micrograph of a fractured particle produced by spray drying
ticles. Both processes can be used to produce SLMs at
low temperatures. However, while spray chilling is used
to produce SLMs, spray coating is used for recovering
particles. Thus, spray coating has the advantage of pro-
ducing reservoir-type microcapsules. During the spray
coating process, the particles are kept in suspension in a
chamber while the coating solution is nebulised over
them. When molten lipid matrices are used as coatings,
the chamber is kept at low temperatures for promoting
solidification of the lipid while recovering the particles.
A wide variety of materials, including lipid mate-
rial, can be used for the coating of particles by spray
coating and spray chilling (23). The use of lipids during
spray coating leads to SLM features similar to those ob-
tained by spray chilling, including the release mecha-
nism. As the spray coating technique allows the thick-
ness of the coating layer to be adjusted, the control of
the release speed of the bioactive compound can be
modulated with more accuracy, thus obtaining a desired
release profile. Another advantage of the spray coating
over the spray chilling technique is the amount of active
material that can be used for encapsulation. Currently,
spray chillers have a limitation of the maximum amount
of active material in the feed. Several spray adaptations
were studied using pneumatic atomising nozzle to ob-
tain microspheres with 30 % solid active ingredients and
50 % liquid active ingredients (10).
Both the spray chilling and spray coating techniques
have the possibility of microencapsulation of thermo-
labile ingredients, including enzymes and microorgan-
isms, but it is necessary to pay attention to the thermal
behaviour of the core and the carrier. Lower melting
points and temperatures reached in the cooling chamber
result in greater chances of success in obtaining particles
without compromising the stability of the active mate-
rial during the encapsulation process.
Spray coating technology presents some advantages
when compared to spray chilling. One of them is the
possibility of adjusting the lipid coating thickness by ad-
justing some process parameters. The spray coating tech-
nique also allows multilayer coating with hydrophobic
or hydrophilic coats, which enables greater flexibility in
the applications of these microparticles in relation to
SLMs obtained by spray chilling when incorporated in
other products. In addition, there are differences in the
structure of the particles obtained by spray chilling and
spray coating. In spray chilling, microparticles are ma-
trix-type particles in which the bioactive component is
dispersed throughout the volume of the microparticles
or microspheres. In spray coating, SLMs are reservoir-
-type microparticles or microcapsules in which the ac-
tive ingredient is enclosed by a layer or multiple layers.
Thus, in the SLMs produced by spray coating, the bio-
active ingredients are better protected compared to the
microparticles obtained by spray chilling because in the
SLMs produced by spray chilling, part of the bioactive
component is dispersed on the surface of the particle.
Process Variables
The following main variables should be strictly mo-
nitored in the spray chilling process: melting point of the
matrix used, temperature of the molten material during
processing, chamber temperature, atomising air temper-
ature, atomising air pressure, and feeding flow of the
molten mixture (8). Table 2 (2,8,10,28,29) summarises sev-
eral operation conditions of the spray chilling process.
The following conditions are critical to obtain uni-
form particles: low viscosity and high speed atomisa-
tion. Das and Gupta (30) studied the micropelletisation
technique using modified spray congealing technology
with a cross-linked gelatin matrix, and they suggested
that the ideal viscosity for this system is approx. 0.024
Pa·s at 55 °C.
The spray chilling performance depends strictly on
the spray atomisation efficiency of the molten mixture.
The efficiency of the atomisation process, in turn, is di-
rectly associated with different types of devices that can
perform the atomisation. These devices (atomisers) may
be pressure nozzles, centrifugal atomisers, rotary atom-
isers, dual fluid atomisers or ultrasonic atomisers (5).
The devices are shown in Fig. 3 (31). All available atom-
isers have similar characteristics, and they all are inade-
quate when spraying mixtures that have high viscosity.
The feeding and pressure conditions employed in the
process can exert effects on the homogeneous distribu-
tion of the particles. Albertini et al. (10) described this
limiting profile assuming the difficulty of atomising a
mixture containing active ingredients in a mass fraction
exceeding 30 %. However, these authors suggested that
by altering the design of the atomiser, there is a possibil-
ity of overcoming the threshold feeding up to 50 % (by
mass).
Some studies have been conducted to investigate the
effects of process parameters on particle features. Ma-
schke et al. (9) found that by increasing the atomisation
pressure from 5 to 6 bar, there is a decrease in the size of
particles obtained by spray chilling. Viscosity is another
important variable that influences the particle size, and
it can be regulated by monitoring the temperature or by
the type and amount of dispersed solids. Low viscosity
(due to high temperature) results in smaller particle
sizes (9), while higher viscosity (for example, due to the
addition of solids) results in larger particle sizes (10).
The molten mixture, which is the feed stream, pres-
ents a characteristic curve of solidification. When the atom-
ised droplets come into contact with the cooled medium,
the material cools to a temperature of solidification.
Thereafter, the temperature remains constant during the
heat release of the product, and stable SLMs are then
formed. Some products that have a variety of fatty acids,
such as hydrogenated palm kernel oil, do not have a
well-defined solidification point. The phase change may
occur in a temperature range, or, depending on the con-
dition of the molten material, the product may migrate
to an amorphous form without releasing the solidifica-
tion heat because a non-crystal formation occurs. The at-
omised material passes through three stages of cooling:
liquid cooling, solidification and particle cooling. The
temperature of the droplets decreases as they come into
contact with cold air. When the solidification tempera-
ture is reached, the droplets will gradually solidify. As
the freshly solidified particles have a higher temperature
than the environment, they continue losing heat until
room temperature is reached.
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Another important approach is to control the tem-
perature of the lipid material during solidification because
it prevents the polymorphism of fats, which directly im-
pacts the release profile of the active material/bioactive
compound. The lipid matrix can crystallise in different
ways depending on different reasons related to the cool-
ing process. For example, rapid cooling results in a lipid
compound preferably in the unstable a form, and slow
cooling tends to lead to the formation of the b form (32).
Currently, several studies have investigated the per-
formance and improvement of spray chillers, including
the use of pneumatic atomising nozzles (10), compact ul-
trasound atomisers (33), and ultrasonic atomisers, to dis-
perse the atomised particles (34).
Ili} et al. (8) studied the influence of several parame-
ters on the obtained particle size when using the spray
chilling microencapsulation process. By varying the at-
omising pressure and liquid feed rate, they reported that
the microparticle median sizes ranged from 58 to 278
mm and that the total process yields range from 81 to 96
%. An increased liquid feed rate was found to increase
microparticle size, and higher atomising pressures were
found to decrease the microparticle size. These authors
concluded that the dominant process parameter regard-
ing microparticle size is achieved by monitoring the at-
omising pressure in relation to the feed rate.
Morphological Characteristics of Particles
Regarding the physical structure, particles produced
by spray chilling are typically matrix-type particles, where
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the active ingredient is dissolved or dispersed through-
out the volume of the particle and not just in its centre.
As this is not a reservoir-type system, where the bio-
active compound is fully covered by the carrier, these
particles cannot be denominated as microcapsules but
are instead denominated as microspheres or micropar-
ticles (for those produced on the micrometre scale). Fig. 4
shows particles or microspheres produced by the spray
chilling technique.
In general, the particles produced by spray chilling
are micrometric and impermeable to water (but not re-
sistant to water). The particles have a spherical form,
which facilitates their flow, and the active ingredient is
normally distributed uniformly within the entire particle
volume (8). These are several essential qualities for a
suitable incorporation of the material due to the reduc-
tion of surface tension between the microparticle hydro-
phobic surface and the aqueous environment to which it
is added, thus allowing the flow of particles in the food
matrix (26). Because the process does not involve sol-
vent evaporation, which is commonly observed in other
techniques such as spray drying, the particles produced
by spray chilling are usually dense and not porous, and
they tend to be mechanically resistant and remain intact
upon agitation (26).
The particle size depends on both formulating and
operating parameters. Formulating parameters include
the size and concentration of the active ingredient as
well as the viscosity of the feed. The operating parame-
ters consist of the configuration of the atomisation de-
vice and working conditions (i.e. disk configuration, disk
rotational speed, air nozzle pressure, and temperature).
An additional coating may be applied to microparticles
obtained by spray chilling, using spray coating technol-
ogy, to ensure a complete coverage of the particle and to
eliminate undesirable interactions during embedding and
storage (26).
Regarding the equipment operational configuration,
there is a specific height to be used to obtain a suitable
fall of particles, and such a parameter depends on the
required particle size and melting characteristics of the
material (14).
Carriers and Additives Used in Food/Feed
Encapsulation
Lipids are interesting alternatives to be used as coat-
ing materials due to their ability to assume a variety of
morphological states, such as emulsions, liposomes and
SLMs (35). Several characteristics of a suitable carrier
should be taken into consideration prior to the process
as follows: regulatory acceptability for use in foods; sta-
bility under typical process conditions; ease of atomisa-
tion; and moderate melting temperature, which is aimed
at minimising the degradation of the filling component
(36). A proper selection of the carrier is important be-
cause it may change some properties of the encapsulated
material, such as control of the release profile, masking
of unpleasant taste, reduction of gastrointestinal irrita-
tion, and increased viability in some media (2,9,37–39).
The use of surfactants directly impacts the stability
of SLMs. The choice of the surfactant agent depends on
the compound to be encapsulated and also on the appli-
cation of the final product. The surfactant should not
provide undesirable characteristics to the final product
(40,41).
The particle release profile can also be influenced by
changes in lipid matrices, concentration of surfactant
(such as soy lecithin) and by some production parame-
ters (42). These surfactants are added to provide greater
stability to the capsule as they aid in effective connec-
tion between the active ingredient and the matrix. Sev-
eral researchers have analysed the incorporation of leci-
thin in the lipid matrix to optimise the incorporation of
the active ingredient, and they showed that the encapsu-
lation efficiency increases linearly with increasing con-
centration of lecithin (up to a certain percentage). This
effect was attributed to the development of micelles in
the middle of the lipid matrix, which contributes to an
additional incorporation of the active ingredient (43).
Release Mechanism
Microencapsulation enables controlled release of the
active ingredient. In response to specific stimuli, the par-
ticle releases its active ingredient in a specific environ-
ment. The release mechanisms of bioactive compound
from solid lipid microparticles in the intestine can be as-
sociated with the presence of digestive enzymes, partic-
ularly pancreatic lipase and bile salts (which act as de-
tergents). Another possible release mechanism is through
the increase of the temperature above the melting point
of the carrier.
The particle type, geometry and composition define
the release mechanism of the active ingredient. The pro-
cesses that employ hydrophilic carriers generally trigger
a more rapid release of the active ingredient in relation
to those agents that have a lipid carrier (fats and waxes),
thus retarding the release of the active compound (44).
The release of active ingredients from particles obtained
by spray chilling can occur via erosion and leaching of
the matrix. Depending on the type and concentration,
some surfactants can dramatically affect the dissolution
rate of the matrix.
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Fig. 4. Micrograph obtained by scanning electron microscopy
(SEM) of particles produced by spray chilling using palm oil as
a carrier (500× magnification)
With regard to SLMs, the release rate can be acti-
vated by enzymatic degradation or temperature. When
activated by enzymes, lipids are degraded by the action
of lipases in the digestive system. When activated by
temperature, the active ingredient is released in re-
sponse to the temperature change affecting the physical
state and release rate of the bioactive compound. In this
context, two distinct concepts should be noted: (i) tem-
perature sensitivity, which is an important characteristic
that needs to be taken into consideration for those mate-
rials that expand or collapse when a critical temperature
is reached, and (ii) activation by fusion, which is related
to the melting of the carrier, such as those made of mod-
ified lipid or wax, in response to the increasing tempera-
ture (45).
With respect to vitamins, which are potentially oxi-
disable compounds, the microencapsulation process can
also increase their chemical stability and improve the
masking of possible off-flavours or odours. In this case,
the vitamin must be released after ingestion or directly
in the stomach or intestines. For this purpose, hydro-
phobic materials are employed, although cellulose deri-
vatives and cross-linked proteins can also promote en-
teral release (46).
The concept of release after ingestion, which reflects
the actual digestion mechanism of the carrier, is con-
nected with the condition of microparticles containing
probiotics. These microorganisms are beneficial to the
host’s health. However, to be effective, the probiotic
strain must remain alive after passing through the stom-
ach because acidic medium and the presence of oxygen
are harmful to the microorganism (47–49). Therefore, the
timing associated with the fact that lipid digestion (car-
rier) effectively takes place in the intestine where the
probiotic strain must act reflects the efficiency and the
basic condition to apply this technique.
In the SLM, not the entire bioactive ingredient is ef-
fectively encapsulated as it remains on the particle sur-
face. This condition leads to a high initial release of this
bioactive compound and is followed by the osmotic dif-
fusion (even if in a small amount) in the matrix. Mecha-
nical breakdowns and melting of the lipid matrix elements
also release the bioactive compound (6). Additionally,
other factors influence the release kinetics, such as os-
motic force, slow diffusion rate of water through the
imperfections of the capsule, and mechanical disruption
(6).
Zaky et al. (50) studied the factors that impact the
release kinetics of protein in triglyceride microparticles
prepared by spray congealing. These authors investigat-
ed the effect of the protein particle size, morphology and
distribution in the release of the encapsulated micro-
particles by confocal laser scanning microscopy (CLSM).
The results showed that water entered and dissolved the
protein, which led to the formation of water-filled pores
allowing the diffusion of the active ingredient in the out-
side part of the matrix. The penetration of water and re-
lease of protein are strongly correlated, showing the im-
portance of more realistic three-dimensional analysis to
study the distribution of the protein within the particle.
Furthermore, SLMs have the advantage of lipids be-
ing easily digested in the intestine by lipases causing the
release of active compounds in the vicinity of their site
of action. Thus, it would be interesting to encapsulate
probiotics, prebiotics, some proteins, peptides, iron, w-3
fatty acids, vitamins, antioxidants and many other com-
pounds.
Advantages of the Process
Currently, the use of spray chilling has increased due
to the numerous advantages associated with the techno-
logical process, such as speed, performance, and relative-
ly low cost. Once this technique does not require the use
of water or organic solvents, the elimination of residual
solvents will not be required. Moreover, it is a fast, safe
and reproducible physical process because it is associ-
ated with an easy adjustment of particle size (51).
In the last two decades, spray chilling has been con-
sidered to be an environmentally friendly technique com-
pared to other procedures, such as spray drying. Spray
chilling also reduces energy use and time of operation
(52). Another positive aspect is the ease to scale up the
production because this technique can be operated con-
tinuously with the elimination of some manufacturing
steps (53).
Other advantages of spray chilling include the use
of low temperature in the process, thus not requiring
heat. Moreover, there is usually controlled release of the
SLM contents around the melting point of the carrier
and by digestion of the carrier in the intestine. The
SLMs are almost perfect spheres, which are structures
that give free-flowing powders.
Disadvantages of the Process
Although SLMs present some advantages, some of
the technological disadvantages are as follows: low en-
capsulation capacity of the active material; possibility of
expulsion of the active ingredient by the matrix during
the particle shelf life; and the degradation of lipid car-
rier applied for the dispersion development, which may
affect the active ingredient material, thereby influencing
its stability and/or its release profile (54).
Another limitation to be considered is the proper
choice of the material to be encapsulated. The encapsu-
lated material should be stable at the carrier melting
temperature. For many thermolabile or unstable food in-
gredients, the degradation temperature is recurrently
low, thereby reducing the possibilities of using a suitable
carrier. The use of molten mixtures should also be con-
sidered, which requires operational attention to avoid
agglomeration and solidification of such materials in the
production line, thus impairing the efficiency of the ato-
misation process.
The method has a drawback related to fast cooling
rates that sometimes crystallise the lipid matrix into a
polymorphic form (unstable a arrangement), which leads
to the development of disordered chains and/or unde-
sirable orientation, thus promoting lower barrier prop-
erties due to the tendency of more stable arrangements
resulting in the release of the active ingredient (32,53).
Other possible disadvantages include the effect of
particles on food texture, which depends on the particle
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size, as well as the possibility of particles to float in liq-
uid systems. In addition, SLMs prepared by spray chill-
ing are insoluble in water due to the lipid carrier, which
can limit or not allow some applications. Moreover, the
matrix structure of the particles obtained by spray chill-
ing leads to the dispersion of the part of the active mate-
rial that is not protected on the surface of the particles.
Encapsulation of Functional Ingredients by
Spray Chilling
Microencapsulation has been widely used in various
industrial applications. However, even though microen-
capsulation by spray chilling has been thoroughly stud-
ied in the last years, especially in the pharmaceutical
and veterinary production, it has just a few food-based
industrial applications. Although the use of encapsula-
tion is fairly new in the food field, the interest in spray
chilling technology has grown significantly. This interest
grows as the need arises to develop alternatives for new
applications. In this regard, the encapsulation of food in-
gredients that present functional properties has been stud-
ied more vigorously.
A common characteristic of many functional ingre-
dients is that they are subjected to rapid inactivation or
degradation (55). Thus, the incorporation of bioactive in-
gredients in foods presents many challenges, especially
with respect to their stability during processing and stor-
age and the need to prevent undesirable interactions with
the food matrix (56). Encapsulation technology arises in
this context as a viable alternative to ensure that the
functional ingredient may be active in the body, that is,
it must be delivered to the site of action at a relevant
concentration for a sufficiently long period of time to do
its work. Furthermore, by encapsulating the active ingre-
dient into a food matrix, the loss of food quality is avoid-
ed, thus ensuring the product’s intrinsic characteristics
(57).
Although rarely studied by food researchers, spray
chilling has several advantages that make it an impor-
tant alternative for encapsulation of functional ingredi-
ents. The process is fast, simple and relatively inexpen-
sive. Moreover, spray chilling can be applied to different
types of functional ingredients, such as vitamins, miner-
als, antioxidant compounds, proteins, protein hydroly-
sates and probiotic microorganisms.
The use of lipid material as a carrier together with
the use of low temperatures and the absence of organic
solvents during the process are some of the advantages
that have encouraged researchers to explore the micro-
encapsulation of food ingredients by means of spray
chilling to overcome technological limitations in their
use. The process has been tested for different purposes,
including the development of controlled release systems
and protection of food ingredients against adverse envi-
ronmental conditions, such as the presence of light, oxy-
gen or unfavourable pH. Furthermore, the process has
been tested for taste masking and encapsulation of fla-
vour ingredients, such as peptides and proteins, with
therapeutic potential.
Encapsulation of Probiotic Microorganisms
Although the first reports involving studies with
probiotics are not recent, the incorporation of these mi-
croorganisms in foods is still considered a challenge to
the industry. Probiotics represent one of the most impor-
tant classes of functional ingredients and are defined as
live microorganisms that, when administered in adequate
amounts, confer a health benefit to the host (58).
To be able to present prophylactic or therapeutic
functions, probiotic microorganisms need to have their
functional structures preserved until they reach their site
of action in a high enough quantity to be capable of pos-
itively influencing the local microbiota (55). However, a
number of factors may compromise the functionality and/
or the viability of probiotic microorganisms. These fac-
tors are related to the technological processes used for
food production, the physicochemical characteristics of
the food matrix to which the probiotic is added and its
passage through the gastrointestinal tract until its arrival
in the intestine, which is its primary site of action (59).
Microencapsulation is a promising alternative to over-
come the problems related to the vulnerability of pro-
biotic cells to adverse factors, including the presence of
oxygen and acidic media (60,61). Various techniques
have been used for the encapsulation of probiotics, and
each technique presents particular advantages and dis-
advantages. Among the available techniques, the follow-
ing are highlighted: extrusion, atomisation or spray drying,
emulsion, coacervation, spray coating and immobilisation
in fat or starch granules (62).
The spray chilling technique has several advantages
in the encapsulation of probiotic microorganisms. The ab-
sence of organic solvents during the encapsulation pro-
cess is one of these advantages. The use of these organic
chemicals is necessary in other techniques and may be
toxic/lethal to the probiotic strains, which compromises
not only the viability but also their functionality.
With spray chilling, it is possible to develop SLMs
only by using the lipid matrix and a probiotic culture
without using any further substance. Furthermore, spray
chilling does not require the application of high temper-
atures to produce the microparticles that contain pro-
biotics, which differs from the spray drying and extru-
sion techniques. However, there is the need to melt the
lipid matrix. It is possible to use fats with a low melting
point, which prevents the microorganism from being af-
fected by the temperature. Another good aspect of the
spray chilling technique is related to the release mecha-
nism of the active ingredient. If the matrix is composed
of fats, the release of the bacteria occurs directly in the
intestine as a result of the action of lipases present in the
intestinal lumen.
Pedroso et al. (2) encapsulated probiotics by spray
chilling using interesterified palm fat and palm kernel,
and they found that the SLMs provided protection for
Bifidobacterium lactis and Lactobacillus acidophilus against
the simulated gastric and intestinal fluids. Moreover,
they obtained promising results for viability during stor-
age when refrigerator and freezer storage temperatures
were applied.
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Pedroso et al. (3) also reported that the encapsula-
tion of B. lactis and L. acidophilus in cocoa fat by spray
chilling provides protection and cell viability. Although
in vivo gastrointestinal studies demonstrate protection,
the viability during storage of SLMs is low. This study
indicated that spray chilling using fat as a carrier is an
innovative technology for the protection, application and
delivery of probiotics. The use of spray chilling favours
the microencapsulation of bacteria mainly because it does
not employ high temperatures or toxic solvents in the
process.
Encapsulation of Vitamins and Minerals
Vitamins may be added to food products to enhance
their nutritional value or to act as additives, such as an-
tioxidants or colouring agents added to cured products.
Herein, essential minerals are usually added to foods to
enhance their nutritional value. The nutrients in these
foods may be hampered by the low stability of vitamins
or by their ability to interact with other food compounds,
thus promoting undesirable changes to the food chem-
ical and sensory properties. Iron is a classic example be-
cause its bioavailability is severely affected by inter-
actions with food compounds (e.g. tannins, phytates and
polyphenols), and iron may also act as a catalyst for the
oxidation of fats and vitamins (56). Microencapsulation
has been studied as an alternative to add these nutrients
to foods. Once more, the choice of the encapsulation
technique is a limiting factor because the vitamin con-
tent and chemical stability can be negatively affected by
several factors related to the microencapsulation process-
es. Some technological features related to spray chilling,
such as not using organic solvents and high tem-
peratures, have stimulated further studies involving the
encapsulation of these nutrients.
To develop a stable salt for the fortification of io-
dine, iron and vitamin A, Zimmermann et al. (63) ap-
plied the spray chilling technique to package potassium
iodate, micronised ferric pyrophosphate, and retinyl pal-
mitate into microcapsules (mean particle size of 100 mm)
using hydrogenated palm oil as a carrier. The purpose of
microencapsulation was to ensure iron bioavailability to
prevent colour changes and to ensure the chemical sta-
bility of iodine and vitamin A. The microparticles were
used in a randomised, double-blind trial that evaluated
the bioavailability of these nutrients and the nutritional
deficit in the studied population. The results showed
that iron, vitamin A and iodate are highly stable when
added to salt, and its use for a six-month period is ef-
ficacious in reducing the prevalence of iron, iodine, and
vitamin A deficiencies in the studied population.
The addition of vitamin E to foods represents an
interesting strategy to ensure its adequate daily intake.
However, the addition of vitamin E into foods may be
difficult due to its chemical instability, that is, it slowly
undergoes oxidation by atmospheric oxygen by means
of a reaction catalysed by light and heat in the presence
of metals. Based on this consideration, Gamboa et al. (28)
used the spray chilling technique to encapsulate a-toco-
pherol using interesterified fat with no trans isomer fatty
acids prepared with fully hydrogenated soybean oil and
soybean oil in the mass ratio of 70:30. The results showed
values for the encapsulation efficiency above 90 %, and
high levels of retention of the active agent were attained.
Thus, the a-tocopherol encapsulation by spray chilling
was successful.
Vitamin C is another important nutrient for food
companies. This vitamin is widely used by the industry
to supplement foods or to act as an antioxidant agent.
However, the stability of vitamin C is considerably re-
duced when it is added to solutions due to the influence
of temperature, pH, and presence of oxygen and metal
ions (64). In a study performed by our research group
(unpublished data), ascorbic acid was encapsulated by
spray chilling using interesterified fat and palm kernel
oil as a carrier. The results showed that the stability of
ascorbic acid was substantially higher compared to free
ascorbic acid. By measuring the instrumental colour, it
was possible to observe a significant colour change in
free ascorbic acid stored at 22 and 37 °C. This effect was
associated with the development of compounds result-
ing from the degradation of ascorbic acid. In contrast,
the colour change observed in the encapsulated ascorbic
acid stored under similar conditions was considerably
smaller, thereby confirming that spray chilling is a use-
ful alternative to enhance the chemical stability of ascor-
bic acid.
Zoet et al. (65) patented microencapsulation of fat-
-soluble vitamins (e.g. vitamin D) by a spray cooling/
chilling process. The process included making a homo-
geneous solution of a fat-soluble vitamin with the fatty
phase preferably being a hydrogenated vegetable oil,
such as palm kernel oil, cotton seed oil, sesame seed oil,
palm oil, carnauba wax or beeswax. These authors sug-
gested that the carrier should have a melting point in
the range from 45 to 90 °C, and their invention relates to
the use of microencapsulated fat-soluble vitamins, which
was defined herein before as an ingredient in animal
feed.
Encapsulation of Proteins and Protein
Hydrolysates
The application of hydrolysed proteins that have a
specific biological activity for the development of func-
tional foods is of great interest for industrial purposes.
However, the bitterness of hydrolysates and their low
structural stability may limit the use of these ingredients
in food products. Additionally, some protein hydroly-
sates are hygroscopic and reactive (66). In this case, en-
capsulation can be useful for masking the bitter taste
and preventing the high reactivity of protein hydroly-
sates, which may cause undesirable changes in food. Al-
though scientific studies are limited in the literature, the
spray chilling technique has been mainly studied for
masking the taste of antibiotics (38).
Taste masking is often cited in the literature as one
of the main purposes of drug/food microencapsulation.
However, spray chilling has not been explored for this
purpose by food companies, and only few studies have
explored the application of spray chilling microencapsu-
lation in the production of drugs. Yajima et al. (38) re-
ported the microencapsulation of clarithromycin, which
is a macrolide antibiotic that has a strong bitter flavour.
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These authors found that when clarithromycin was micro-
encapsulated using glyceryl monostearate and amino-
alkyl methacrylate copolymer, the drug did not dissolve
in the mouth but instead was released immediately in
the intestinal tract, resulting not only in taste masking
but also offering a high bioavailability.
Another application of spray chilling that has not
been fully explored is the microencapsulation of proteins
and peptides. Although the use of these components in
pharmaceutical formulations has experienced rapid growth
since 1980 with the advent of recombinant DNA techno-
logy, the development of delivery systems is still con-
sidered challenging due to difficulties in maintaining the
stability of proteins (67).
The choice of the technique for encapsulation is li-
mited by the need for maintaining the integrity and bio-
activity of the protein, and the use of high temperatures
and organic solvents are two factors that can be directly
linked with protein denaturation (68). Taking this into
consideration, the use of spray chilling can be advanta-
geous because the process does not require the use of
organic solvents or elevated temperatures. Moreover, car-
riers that have a high biocompatibility, such as triacyl-
glycerides, are used in formulations for parenteral de-
livery (9). Several publications have addressed the use
of microencapsulation for the development of controlled
release systems for peptides and proteins of high thera-
peutic potential, including lactase (69), somatostatin (70),
insulin (9), growth hormone (71) and casein hydrolysate
(72). Recently, a study conducted by Maschke et al. (9)
showed positive results regarding the stability of insulin
towards the spray chilling microencapsulation process.
Using glycerol tripalmitate as the carrier, these authors
demonstrated that it is possible to obtain spherical mi-
crocapsules with different protein fractions (0.5, 1 and 2
%) with particle sizes between 182.2 and 315 mm, and
their experimental results also showed that insulin is re-
leased for at least 28 days, indicating a possible release
for up to six months.
Di Sabatino et al. (73) produced lipid-based particu-
late systems by a spray congealing technique using bo-
vine serum albumin as the model protein, and they re-
ported that the solvent-free drug encapsulation process
can be successfully employed to obtain particles with
high (10–20 % by mass) protein loading without altering
its structure.
Despite the therapeutic potential of some peptides,
proteins and protein hydrolysates, their low structural
stability (especially for proteins), bitter taste (of some
peptides and hydrolysates), hygroscopicity, allergenicity
and reactivity represent obstacles for their use with the
aim to produce functional foods. In addition, some of
these products should not be digested before they reach
the gut because digestion can destroy their therapeutic
effect. Consequently, the use of these protein hydroly-
sates is challenging for both food industries and re-
searchers. Microencapsulation by spray chilling technol-
ogy may be an alternative for reducing these problems.
As this process does not require the use of organic or
aqueous solvents and high temperatures, it could be suit-
able for protection and production of protein delivery
systems.
Conclusions
Although spray chilling encapsulation is not a new
method, it is exploited to a lesser extent compared to
spray drying encapsulation, especially in the food sci-
ence field. In the last 10 years, however, mainly in the
veterinary and pharmaceutical fields, there has been a
significant increase of published papers involving spray
chilling microencapsulation. Many recent research arti-
cles have aimed at understanding the process variables
of spray chilling encapsulation and to propose changes
in the equipment and/or procedures, as well as to pro-
pose new carriers in order to improve the process per-
formance in relation to the development of microparti-
cles. It is likely that with the increase of successful reports
on spray chilling encapsulation, more researchers will be
interested in using this technique, thus enabling further
studies and new applications in various technological
fields.
This technique represents an excellent alternative for
encapsulation of various food ingredients with the pos-
sibility of providing controlled release, taste and aroma
masking as well as conferring a remarkable stability for
different compounds. In addition to the above-men-
tioned applications, the use of spray chilling technique
has a potential to address many other limitations in the
food industry, such as the reduction in the volatility of
flavourings and the hygroscopicity of powders, without
excessively increasing the commercial value of food in-
gredients once it becomes a low-cost technique.
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